Elevated SARS-Cov-2-Specific IgM Levels Indicate Clinically Unfavorable Outcomes in Patients with COVID-19: A Retrospective Cohort Study

BACKGROUND: COVID-19 outbreak began in Wuhan and pandemics occur. Although SARS-CoV-2-specific immunoglobulins have been detected in serum of COVID-19 patients, their dynamics and association with outcomes have not been fully characterized. METHODS: This retrospective cohort study investigated the a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Zhiquan, Li, Jingjing, Yang, Chunguang, Chen, Fen, Wang, Zhihua, Lei, Ping, Shen, Guanxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721030/
https://www.ncbi.nlm.nih.gov/pubmed/35002299
http://dx.doi.org/10.2147/IJGM.S322971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721030/
https://www.ncbi.nlm.nih.gov/pubmed/35002299
http://dx.doi.org/10.2147/IJGM.S322971

Ejemplares similares